0001437749-24-007350.txt : 20240311 0001437749-24-007350.hdr.sgml : 20240311 20240311180101 ACCESSION NUMBER: 0001437749-24-007350 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240307 FILED AS OF DATE: 20240311 DATE AS OF CHANGE: 20240311 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LEDOUX MARK A CENTRAL INDEX KEY: 0001115556 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15701 FILM NUMBER: 24739468 MAIL ADDRESS: STREET 1: 1185 LINDA VISTA DR CITY: SAN MARCOS STATE: CA ZIP: 92069 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NATURAL ALTERNATIVES INTERNATIONAL INC CENTRAL INDEX KEY: 0000787253 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 841007839 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 BUSINESS PHONE: 7607367700 MAIL ADDRESS: STREET 1: 1535 FARADAY AVENUE CITY: CARLSBAD STATE: CA ZIP: 92008-7319 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN ACQUISITIONS INC DATE OF NAME CHANGE: 19860929 4 1 rdgdoc.xml FORM 4 X0508 4 2024-03-07 0000787253 NATURAL ALTERNATIVES INTERNATIONAL INC NAII 0001115556 LEDOUX MARK A 1535 FARADAY AVENUE CARLSBAD CA 92008 1 1 1 CEO/Chairman 0 Common Stock 2024-03-07 4 F 0 5777 5.95 D 149121 D Common Stock 2024-03-08 4 A 0 17000 0 A 166121 D Common Stock 481905 I By LeDoux Family Limited Partnership Common Stock 69416 I By IRA Common Stock 7200 I By Self as Custodian for Marcelle Jeannette LeDoux Common Stock 800 I By Self as Custodian for Jean-Marc Emile LeDoux Common Stock 7500 I By Self as Custodian for Aimee LeDoux This transaction represents a resale of 5,777 shares to the Issuer as payment of the reporting person's tax liability upon vesting of 13,666 shares of restricted stock on March 7, 2024, using the closing stock price on March 7, 2024, of $5.95 per share. This transaction represents a grant of restricted stock pursuant to the Issuer's 2020 Omnibus Incentive Plan. One third (5,667 shares) of the restricted stock vests on March 7, 2025; one third (5,667 shares) of the restricted stock vests on March 7, 2026, and the final third (5,666 shares) of the restricted stock vests on March 7, 2027. /s/ By Kenneth E. Wolf Attorney in Fact 2024-03-11